Dan Levitt

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

Gordon C. Jayson, Jamal Zweit, Alan Jackson et al. · JNCI Journal of the National Cancer Institute · 2002 · 257 citations · Full text

Medicine, Oncology, Cancer Pharmacology +16

Telomerase Activity and Survival of Patients With Node-Positive Breast Cancer

Gary M. Clark, C. K. Osborne, Dan Levitt et al. · JNCI Journal of the National Cancer Institute · 1997 · 141 citations

Medicine, Molecular Biology, Oncology +17

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

Scott A. Halperin, Simon Dobson, Shelly McNeil et al. · Vaccine · 2005 · 133 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Phase I study of interleukin-2 and interferon alfa-2a as outpatient therapy for patients with advanced malignancy.

M Hirsh, Allan Lipton, H Harvey et al. · Journal of Clinical Oncology · 1990 · 70 citations

Pharmacy, Oncology, Pharmacotherapy +17

Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer

Gordon C. Jayson, C Mulatero, Malcolm Ranson et al. · European Journal of Cancer · 2005 · 50 citations

Pharmacy, Immunology, Oncology +12